Need all Congresses? Press Enter for expanded federal results.
HR 2855
116th Congress • 2019-2021 (Ended)

To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.


HR 2855
May 20, 2019
Referred to the Subcommittee on Health.